US Edition
News from braziljournal.com
We’ve assigned a rating of Unknown factuality to braziljournal.com. You can read more about how we’ve determined braziljournal.com’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top braziljournal.com News
PharmaRetatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced.In fact, some of the participants dropped out of the trial because they were losing too much weight, the pharmaceutical company said.Retatrutide is an experimental triple agonist medication, mimicking three different gut hormones in the body GLP-1, G…See the Story
Eli Lilly's Next-Gen Obesity Drug Shows Biggest Weight Loss yet in Clinical Trial
62% Center coverage: 24 sources
